The lessons learnt from this change are explored by Smith et al. 5 and will have implications for any future changes to other programs.
The possibility of a risk-stratified approach is now being explored for potential application within the Australian breast cancer screening program. As knowledge grows about the role of risk factors such as genomic alterations, it may be time to consider applying risk stratification within the program. A potential approach to achieving this is outlined by Nickson et al. 6 The potential for earlier diagnosis of other cancers through screening is an important consideration. For skin and prostate cancers, the Australian health system already funds opportunistic clinical evaluation, but with no ability to determine the benefits, harms or costeffectiveness of this approach. The large burden of lung cancer incidence and its ensuing mortality cries out for earlier diagnosis, as does the rising burden of liver cancer in our community. The question of what to do about individuals at higher risk of a range of cancers, such as people with Lynch syndrome, challenges our current systems. These issues are explored by a range of authors in the first perspective paper 7 in this edition. The overall theme of this issue is that for the benefits of screening to be maximised, we must be prepared to engage in ongoing analysis of program effectiveness, and be open to considering program changes to balance benefits, harms and costs. To do this well, we must invest in linked datasets that enable more complex understandings of the varying impacts of early diagnosis and improvements in treatment on mortality and survival across our community. Throughout this issue, the challenges of effective screening for hard-to-reach populations, such as Aboriginal and Torres Strait Islander people, are raised but not solved. If we are to address the rising gap in outcomes between groups in our community, we must be able to understand the nature and root causes of these variations.
We hope you enjoy this themed issue on cancer screening. Our thanks to the Guest Editors, Karen Canfell, David Roder and Paul Grogan, as well as all the authors who have contributed papers. Thanks too to the many peer reviewers that allowed us to bring you this unique and forward-thinking set of high-quality papers, offering insights into the challenges and future directions for cancer screening in Australia.
